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Alda and colleagues [1] present a well-designed and 
implemented randomized trial (RCT) comparing 
cognitive-behavioral therapy (CBT), pharmacotherapy, 
and treatment-as-usual for patients with ﬁ  bromyalgia 
(FM). I commend their inclusion of a pharmacotherapy 
comparison, assessment of mediators and outcomes, and 
6-month follow-up. CBT improved several outcomes, 
adding to a growing literature supporting CBT for FM.
But how well does CBT work for FM? A critical look at 
this and similar studies shows that the beneﬁ  ts - although 
non-zero - are rather modest clinically. Th   e largest eﬀ  ects 
in this study (approximately one standard deviation 
compared with treatment-as-usual) were for pain catas-
tro  phizing and acceptance. But these are actually change 
processes or mediators directly targeted by CBT, not 
outcomes of clinical interest. In contrast, there were 
moderate-sized eﬀ  ects on overall FM impact and quality 
of life, small eﬀ  ects on depression and anxiety, and - of 
greatest concern - no eﬀ  ects on pain. Th  ese results are 
generally consistent with recent meta-analyses [2,3], 
which report non-zero but rather modest beneﬁ  ts of CBT 
for FM. Overall, it appears that only a minority of FM 
patients - perhaps one-third - demon  strate clinically 
meaningful improvement from CBT and other psycho-
logical/behavioral interventions [4].
Are small to moderate eﬀ  ects and a minority of patients 
improving the limit of eﬀ   ectiveness of psychological 
interventions for FM? Do genetics, long-term central 
nervous system sensitization, and socioeconomic contin-
gencies simply ‘account for more variance’ and trump the 
inﬂ  uence of psychological processes? Perhaps, but I argue 
that we do not yet know, because our intervention eﬀ  orts 
have not been guided by the larger literatures on eﬀ  ective 
psychological therapies and pathological processes in 
FM.
I ﬁ   nd a tendency, especially in medical settings, to 
equate CBT with ‘eﬀ  ective psychological therapy’ and to 
contrast it with one alternative - ‘talk therapy’. Th  is is 
incorrect. CBT is one of many psychological inter  ven-
tions that have proliferated over the past few decades, 
many of which are active, time-limited, and - most 
importantly - beneﬁ   cial. Furthermore, psycho  therapy 
research has identiﬁ   ed general processes that predict 
positive outcomes across a range of psychological 
therapies. Five such processes are: a) providing a new 
rationale for the problem and how to change it; b) 
teaching symptom and self-management skills; c) experi-
encing and processing avoided emotions and memories; 
d) encouraging behaviors that have been avoided, usually 
due to negative emotions (for example, fear, guilt); and e) 
providing a supportive therapeutic relationship that also 
corrects faulty interpersonal expectations [5]. Th  e 
primary focus of CBT for FM is providing the rationale 
of, and teaching cognitive and behavioral skills for, 
symptom management. CBT for pain typically does not 
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avoided emotional experiences (except pain exposure 
exercises, which are probably helpful), or use the thera-
peutic relationship as a change vehicle.
How is this relevant to FM? Many studies have found 
elevated rates of trauma, victimization, and interpersonal 
conﬂ  ict among people with FM - at least among patients 
actively seeking treatment [6]. Such trauma and the 
subsequent avoidance of emotional processing lead to the 
increased post-traumatic stress disorder found in FM [7]. 
Suppressed and dysregulated anger, emotional unaware-
ness and confusion, and reactivity to interpersonal 
conﬂ  ict are increased in FM. Th   e elevated pain catastro-
phizing targeted by Alda and colleagues [1] encompasses 
rumination, helplessness, and somatic magniﬁ  cation  - 
common consequences of unresolved stress.
Should we target for treatment the unresolved stress in 
patients with FM? If so, how? Interestingly, eﬀ  ective 
treatments for trauma and post-traumatic stress disorder, 
which encourage experiencing, expressing, and process-
ing of stress-related emotional memories, remain largely 
untested for those FM patients who have victimization 
histories and emotional avoidance [8]. Th  ere are a 
handful of small trials indicating the beneﬁ  ts to people 
with FM of private writing about stress, group therapy 
for enhancing emotional awareness, and individual 
therapy targeting unresolved stressors [9]. It is note-
worthy that Alda and colleagues actually included two 
ancillary exercises that activate avoided emotions - 
expressive writing and assertive communication. I 
applaud this, but encourage testing of interventions that 
have emotional processing as a primary target.
Perhaps we fear that patients will respond negatively to 
such an intervention - rejecting it, feeling stigmatized, 
and having increased symptoms. Such interventions also 
are emotionally challenging for therapists. We should 
not, however, let our fears prompt avoidance of 
potentially adaptive experiences. Colleagues and I are 
testing an intervention that has FM patients confront and 
process avoided emotional experiences and relationships, 
and are comparing it to CBT and an educational control. 
We do not yet know this intervention’s eﬀ  ects, how it 
compares with CBT, and importantly - given the hetero-
geneity of FM - which patients beneﬁ  t most from each 
approach [10]. However, our initial observations are that 
almost all of our patients acknowledge that stress contri-
butes to their FM symptoms, and patients ﬁ  nd  that 
confronting avoided emotions immediately inﬂ  uences 
their pain, which powerfully demonstrates the relevance 
of their emotions. I encourage researchers, clinicians, 
and patients to be courageous and develop, test, and - if 
empirically supported - implement interventions that 
directly address the unresolved stressors experienced by 
many patients with FM.
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